Suchergebnisse - "Rong, Alan"

PubPharm (8)

1

Comparison Between Simultaneous and Sequential Utilization of Safety and Efficacy for Optimal Dose Determination in Bayesian Model-Assisted Designs

enthalten in: Therapeutic innovation & regulatory science | 2023

von Li, R. | Takeda, K. | Rong, A.

2

Statistical Design of Non-Inferiority Multiple Region Clinical Trials to Assess Global and Consistent Treatment Effects

enthalten in: Journal of biopharmaceutical statistics | 2017

von Diao, G. | Zeng, D. | Ibrahim, J. | +4

3

Pattern mixture models for clinical validation of biomarkers in the presence of missing data

enthalten in: Statistics in medicine | 2017

von Gao, F. | Dong, J. | Zeng, D. | +2

4

Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer

enthalten in: Cancer treatment reviews | 2015

von Hecht, J. | Douillard, J. | Schwartzberg, L. | +5

5

Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer

enthalten in: The New England journal of medicine | 2013

von Douillard, J. | Oliner, K. | Siena, S. | +19

6

O-0031 * EVALUATION OF KRAS, NRAS, AND BRAF MUTATIONS IN PRIME: PANITUMUMAB WITH FOLFOX4 AS FIRST-LINE TREATMENT IN METASTATIC COLORECTAL CANCER (MCRC)

enthalten in: Annals of oncology | 2013

von Oliner, K. | Douillard, J. | Siena, S. | +17

7

Evaluation of Progression-Free Survival as a Surrogate Endpoint for Survival in Chemotherapy and Targeted Agent Metastatic Colorectal Cancer Trials

enthalten in: Clinical cancer research | 2013

von Sidhu, R. | Rong, A. | Dahlberg, S.

8

Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2010

von Peeters, M. | Price, T. | Cervantes, A. | +17

1
[1]